Skip to content

MANE · NYSE

Veradermics (MANE) Stock Price & Fundamentals

$467.78−0.91%−$4.29End-of-day price as of Oct 9, 2026

Veradermics (MANE) closed at $467.78 on Oct 9, 2026, down 0.91% from the previous close of $472.07.

Share price, past year

1Y +50.51%

52-week range $308.49 – $472.07. Daily closing prices.
Monthly closing prices
Last closing price of each month
DateClose
Oct 9, 2026$467.78
Sep 30, 2026$467.50
Aug 31, 2026$467.59
Jul 31, 2026$444.16
Jun 30, 2026$432.10
May 29, 2026$387.91
Apr 30, 2026$385.56
Mar 31, 2026$361.24
Feb 27, 2026$362.71
Jan 30, 2026$359.81
Dec 31, 2025$358.47
Nov 28, 2025$360.59
Oct 31, 2025$335.51

Key statistics

Market cap
$19.54B
Shares outstanding
41.8M
52-week range
$308.49 – $472.07

Veradermics's market cap is $19.54B, based on a share price of $467.78 and 41.8M shares outstanding as of Jun 30, 2026.

Financials

Veradermics's SEC filings don't report revenue in the standard form Laurel reads, so its revenue history isn't shown yet.

Veradermics reported a net loss of $70.00M in fiscal 2025.

Company profile

Name
Veradermics, Inc
Ticker
MANE
Exchange
NYSE
Industry (SEC SIC)
Pharmaceutical Preparations
Headquarters
470 James Street, New Haven, CT 06513
Incorporated in
DE
Fiscal year ends
December
SEC CIK
0001827635

Recent SEC filings

Frequently asked questions

What is Veradermics's stock price?

Veradermics (MANE) closed at $467.78 on Oct 9, 2026, down 0.91% from the previous close of $472.07.

What is Veradermics's market cap?

Veradermics's market cap is $19.54B, based on a share price of $467.78 and 41.8M shares outstanding as of Jun 30, 2026.

Sources and methodology

Fundamentals come from Veradermics, Inc's filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures